ASHR institutional options flow analysis — multi-leg block trades, dominant direction, and gamma analysis from the public options tape for July 1, 2026. Articles older than 60 days are public; sign in to read flow within the past month, upgrade to AIme Premium for today's unusual options trades without the delay.

ASHR Unusual Options Activity — 2026-07-01

Institutional flow on 2026-07-01

Multi-leg block trades, dominant direction, and gamma analysis

$2.3M1 trade
Long Put

Trade Details

BUY$33 PUT2027-01-15$2.3MLong Put

Full Analysis

🤝 ASHR $2.3M Delta-Hedged China Put Cross — Paired With 399,000 Shares, Not a Bearish Bet

📅 July 1, 2026 | 🤝 Block Cross Detected

✅ Updated 2026-07-02: next-day OPRA OI confirms the OPEN — see the RESOLVED box.


🎯 The Quick Take

At 14:08 ET today, a desk crossed ≈$2.3M in ASHR January 2027 $33 puts — but the full OPRA tape tells a completely different story than the headline number suggests: at the exact same instant, 399,000 shares of ASHR were crossed at $36.39, creating a near-perfect delta-neutral package where the put is the insurance and the stock is the core position. This is a 🤝 BLOCK CROSS paired with a matched equity block — a pre-arranged, off-book hedged structure most consistent with a large long China A-shares position buying downside protection, not a fresh bearish bet on China falling.


📊 ETF Overview

Xtrackers Harvest CSI 300 China A-Shares ETF (NYSE Arca: ASHR) is issued by Xtrackers / DWS (Deutsche Bank's asset-management arm) and sub-advised by Harvest Global Investments. Tracking the CSI 300 Index — the 300 largest, most-liquid A-share companies listed in Shanghai and Shenzhen — ASHR was the first U.S.-listed ETF to offer direct exposure to mainland China onshore stocks. That makes it a nearly pure macro-and-policy vehicle: its NAV is driven more by Beijing's monetary stance, the RMB exchange rate, and foreign-flow sentiment than by any single company's fundamentals. Source: DWS/Xtrackers.

  • Current Price: ≈$36.40 (intraday July 1, 2026)
  • AUM / Net Assets: ≈$1.8B (StockAnalysis)
  • Expense Ratio: 0.65%
  • P/E (TTM): ≈17.1x — undemanding versus U.S. large-cap peers
  • 52-Week Range: $27.31 – $37.33
  • YTD Return: +9.2% — beating SPY's +7.2% (Morningstar)
  • Top Holdings: Kweichow Moutai, CATL (Contemporary Amperex), Ping An Insurance
  • Sector: Broad China A-share large-cap: Consumer Staples, Financials, Industrials/EV-battery, high-tech manufacturing

The CSI 300 sits at ≈5,031 as of early July 2026 — its highest level since December 2021, up ≈30% over the trailing twelve months — driven by a firming yuan, AI/hardware enthusiasm, and foreign capital returning to A-shares. Northbound (foreign) flows have turned constructive as USDCNY broke below the psychological 7.00 level — a "confidence loop" where a firmer yuan cuts FX risk and draws more foreign capital into the rally, reinforcing both the currency and the equity move.


💰 The Option Flow Breakdown

📋 What Just Happened

At 14:08:57 ET on July 1, 2026, a desk executed a 13,300-contract block of ASHR January 15, 2027 $33 puts at $1.75 each — ≈$2.3M in option premium. The mechanism was a 🤝 BLOCK CROSS: a Qualified Contingent Cross (QCC), a pre-arranged off-book trade between two parties who already agreed on price, with no open-market urgency or aggression.

At the exact same moment, 399,000 shares of ASHR were crossed at $36.39 via a Cash-Only / Qualified-Contingent-Trade (QCT) stock block — worth ≈$14.5M. The simultaneous tick is the key tell: a put cross paired tick-for-tick with a matched equity block is the signature of a delta-hedged married-put package.

The Delta Math (independently computed, Black-Scholes):

  • Put delta for an ≈9% OTM put with ≈6.5 months to expiry at current IV: ≈ −0.272 per share
  • Delta exposure from 13,300 puts: 13,300 × 100 × (−0.272) = ≈ −361,760 shares (net short delta from the option)
  • To make the full package delta-neutral, you need ≈ 361,760 shares of long stock to offset
  • Actual stock block crossed: 399,000 shares → 90.5% delta match

Net portfolio direction at execution: roughly flat to slightly long (≈ +37,000 shares equivalent net delta). This is not a directional bearish bet.


📊 Full Trade Details

TimeBuy/SellCall/PutExpirationPremiumStrikeVolumeOISizeSpotOption PriceOption SymbolFlow Type
14:08:57 ETBUYPUT2027-01-15≈$2.3M$3313,0001,20013,300$36.40$1.75ASHR20270115P33🤝 BLOCK CROSS

Paired Equity Leg (same instant, tape-verified): 399,000 shares of ASHR crossed at $36.39 via a Cash-Only + Qualified-Contingent-Trade stock block (≈$14.5M notional). This is the equity component of the delta-hedged package — not a standalone stock trade.


Open / Close — RESOLVED: July 2 Pre-Market OPRA OI Confirms an OPEN

The July 2 pre-market OPRA snapshot (reflecting July 1 EOD) is now in. Verdict: OPEN CONFIRMED. Open interest at the Jan-15-2027 $33 put rose almost exactly in line with the print, so this was a genuine new opening long-put position (BTO).

LegBaseline OI (EOD 6/30)Resolving OI (EOD 7/1)ΔTrade SizeVerdict
ASHR Jan-15-2027 $33 Put1,22114,067+12,84613,000✅ OPEN

OI rose by ≈12,846, closely matching the 13,000-contract size — the opening (BTO) read is confirmed.


🤓 What This Actually Means — Plain English

Let me decode this trade from the ground up, because the headline number ("$2.3M China put buy") is genuinely misleading without the full tape.

What a BLOCK CROSS is: A block cross is a pre-negotiated, off-book trade between two known counterparties — think of it like two people agreeing to sell a house at a price they already discussed privately, then formalizing the paperwork. Nobody "swept the market." Nobody panicked. There is no open-market urgency here. A block cross is the opposite of a sweeping aggressive buy — it's a handshake between professionals.

Why buying puts + buying stock at the same time does NOT equal "betting on China falling": Imagine you manage a $14.5M allocation to China A-shares through ASHR. You're committed to the position — you believe in the CSI 300 trend, the yuan strength, the PBOC easing runway. But you have six big binary macro events coming up (Q2 GDP, Politburo, monthly LPR fixings, tariff truce renewal) and you want to insure against a tail scenario.

So you buy a block of ASHR shares AND simultaneously buy put options as insurance. The puts cap your downside if China policy disappoints or the tariff truce collapses. The stock is the core position; the put is the seatbelt. Because you bought both at the same time in matched sizes, your net directional exposure is roughly flat — you haven't made a bet on "China going down," you've made a bet on China with downside insurance attached.

That is what a married put or protective put structure looks like. It's one of the most conservative options strategies in existence.

Order type: BTO (Buy to Open) for the put leg — size ≫ OI strongly suggests a new opening position. But the context is everything: this BTO is the insurance leg of a delta-neutral protective package, not a naked bearish position.

What the $33 strike means: ASHR is at $36.40 today. The $33 put is ≈9.3% out of the money. For the put to pay off at expiration (January 15, 2027), ASHR needs to fall below $33 — that would require a meaningful China macro shock (tariff breakdown, sharp yuan reversal, major policy disappointment). The institution paid ≈4.8% of spot ($1.75 / $36.40) for this tail protection. That's the insurance premium — the cost of knowing you won't get wiped out if the worst happens.

What the tape cannot tell us (be honest about these):

  • Whether the 399,000-share stock leg represents a new purchase or a roll within an existing position — the sign of the stock leg matters but cannot be confirmed from public OPRA data alone
  • Whether the put buyer and stock buyer are the same account, or two separate accounts crossed by the same broker
  • The identity, broker, or fund of either counterparty

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

ASHR YTD Chart

ASHR has been a steady outperformer in 2026 — up +9.2% YTD against SPY's +7.2%. The ETF climbed from ≈$33 at year-start to the $36-37 zone, now approaching 52-week-high territory at $37.33. The uptrend has been orderly rather than parabolic, underpinned by the yuan's sustained appreciation through the 7.00 level and ≈30% trailing-12-month gains in the CSI 300 index.

Key chart observations:

  • 📈 Steady uptrend since late 2025, accelerating as USDCNY broke below 7.00 and foreign flows turned constructive
  • 🎯 52-week high at $37.33 — today's price at $36.40 puts ASHR within 2.5% of a multi-year breakout level
  • 📊 CSI 300 at ≈5,031 — highest since December 2021, providing conviction for the underlying trend (Trading Economics)
  • ⚠️ Near-term consolidation zone — approaching the 52-week high with binary macro catalysts (Q2 GDP, Politburo) on the immediate horizon

Gamma-Based Support & Resistance Analysis

ASHR Gamma S/R

The gamma exposure map for ASHR shows a tightly structured name with clearly defined walls immediately above and below current price:

🔵 Support Levels (Put Gamma Floors — Blue Bars Below Price):

  • $36.00 — Very Strong (Total GEX: 11.10): Only 1.1% below current price ($36.40). Heavy combined call and put gamma at this strike — market makers hold significant positions that create mechanical buying if ASHR dips here. This is the first and most important near-term floor. Put GEX alone is 6.85 at this strike.
  • $35.00 — Strong (Total GEX: 7.25): Second major put-gamma cluster, ≈3.8% below current price. Net GEX is −4.37 (heavily put-dominated), meaning dealer hedging creates natural support. Break here and the next floor is around $34.00.
  • $34.00 — Moderate (Total GEX: 2.86): Deeper support zone at the lower boundary of the monthly implied move. Thinner than $35 but still present.

🟠 Resistance Levels (Call Gamma Ceilings — Orange Bars Above Price):

  • $36.50 — Very Strong (Total GEX: 9.74): Just 0.3% above current price. This is the first ceiling — heavy call gamma compressed immediately above the current level. Market makers will systematically sell into rallies here to delta-hedge their calls. Piercing $36.50 cleanly requires a real macro catalyst.
  • $37.00 — Strong (Total GEX: 8.84): 1.7% above current price. Net GEX +7.06 (call-dominated). Sustained buying needed to push through this level.
  • $38.00 — Dominant Call Wall (Total GEX: 15.63): The big resistance, 4.4% above. Almost entirely call gamma (15.58 of 15.63 total GEX). This is the 🟠 Call Wall — the level that would require a meaningful positive catalyst (e.g., July Politburo adding explicit easing language) to clear. This aligns almost exactly with the monthly implied move upper bound of $38.41.

What this means right now: ASHR is sandwiched between $36.00 support and $36.50 resistance — a range of only 50 cents. The name is tightly pinned near current levels. A catalyst breaks the range: bullish break targets $37.00 then $38.00 call wall; bearish break targets $35.00 then $34.37 (monthly implied floor). The $33 put strike in this trade sits in very thin gamma territory (total GEX only 0.26 at $33) — correctly positioned as a tail-risk hedge far outside the normal expected range.


Implied Move Analysis

ASHR Implied Move

The options market is pricing ASHR's forward uncertainty across horizons as follows:

HorizonExpiryImplied MoveRange
📅 WeeklyJuly 2, 2026 (1 day)±1.55% / ±$0.57$35.82 – $36.96
📅 Monthly OPEXJuly 17, 2026 (16 days)±5.54% / ±$2.02$34.37 – $38.41
📅 Quarterly (Triple Witch)Dec 18, 2026 (170 days)±18.03% / ±$6.56$29.83 – $42.95
📅 This Trade's ExpiryJan 15, 2027 (≈198 days)$29.51 – $43.27
📅 Yearly LEAPSJan 21, 2028 (569 days)±30.37% / ±$11.05$25.34 – $47.44

Key takeaways for this specific trade:

  • The $33 put strike sits well below the monthly implied-move floor ($34.37). To be in the money at July 17 OPEX, ASHR would need to drop ≈9.3% in just 16 days — something the monthly market is pricing at very low probability. Over the January 2027 horizon, the lower bound is $29.51, so $33 IS within the cone but represents a meaningful drawdown scenario (the kind only a major macro shock would produce).

  • The $38.00 call wall lines up almost exactly with the monthly implied move upper bound ($38.41). Options are pricing the Politburo/GDP catalyst window as approximately a one-standard-deviation move to get there.

  • For the institution's hedge: the implied move cone for the January 2027 OPEX ($29.51–$43.27) means $33 is within the uncertainty range but in the lower tail. The $1.75 premium (≈4.8% of spot) is a reasonable cost for tail protection against the tariff truce breakdown or RMB reversal scenario.


🎪 Catalysts

🔥 Near-Term (Next 15–45 Days)

Q2 2026 GDP — ≈July 15, 2026

The National Bureau of Statistics releases Q2 GDP ≈15 days after quarter-end — just 2 days before the July 17 OPEX. After a strong Q1 at 5.0% YoY, Q2 is expected around 4.6–4.9% (Polymarket consensus). This is genuinely two-sided for ASHR:

  • Soft Q2 print (< 4.5%): Raises stimulus odds — PBOC easing sooner, Politburo may add explicit RRR/rate-cut language. 📈 Bullish for ASHR via policy-hope premium.
  • Hot Q2 print (≥ 5.0%): Delays easing — the "good news is bad news" trap. Resilient growth reduces urgency. 📉 Could briefly disappoint an easing-priced market.

Late-July 2026 — Politburo Economic Meeting

The April Politburo meeting pivoted toward "structure over stimulus," notably omitting explicit rate/RRR-cut language. The July meeting sets the H2 2026 tone and is the single most-watched near-term China policy catalyst. July Politburo language on easing is the key binary for ASHR near-term direction:

  • Explicit easing added: ASHR targets $37.00–$38.00 (gamma walls; monthly implied upper bound).
  • Vague again: Consolidation range; $36.00 support tested.

NBS Manufacturing PMI — Early July June NBS Manufacturing PMI came in at 50.3 — third consecutive month of expansion, with new orders back above 50 at 51.2. Manufacturing momentum remains the floor under the CSI 300 rally. Monthly PMI (first trading day of each month) is a steady pulse check.

📅 Medium-Term (Next 2–6 Months)

PBOC Easing Runway

The PBOC cut the 7-day reverse-repo 10bp and lowered the RRR 50bp in May 2026. The LPR has been held for 13 straight months as of June 2026, but Governor Pan Gongsheng confirmed further RRR and rate cut room exists in H2. Base case: at least one more RRR cut if H2 data softens. Each monthly LPR fixing (20th of the month) is a potential surprise catalyst.

November 10, 2026 — Tariff Truce Renewal Deadline

The November 2025 U.S.-China trade deal lowered U.S. tariffs to 30% and paused reciprocal tariffs until November 10, 2026. The May 2026 Trump-Xi summit reinforced the "stabilization" narrative. Renewal (analysts lean this way) keeps the bull case intact — this date falls squarely within the January 2027 put window. This is likely one of the tail risks the institution is hedging.

Yuan Trajectory

The USDCNY confidence loop — where a firmer yuan attracts foreign capital, which further supports the yuan — is the structural driver of the ASHR rally. Consensus sees gradual CNY appreciation toward ≈6.80–6.75 by end-2026. A reversal of yuan strength would break this loop and directly compress USD-denominated ASHR NAV.

December 2026 — Central Economic Work Conference (CEWC)

The December 2026 CEWC sets the 2027 growth target and fiscal-deficit path. The 2025 CEWC locked in a ≥4%-of-GDP fiscal stance tilted toward consumption. The 2026 CEWC, also within the put's window, will frame whether China accelerates or pares back — a multi-month framing event for A-shares.


💡 Four Investor Perspectives

🎰 YOLO Trader — Playing the Catalyst Window

The setup: Q2 GDP ≈July 15 + Politburo late July = two binary China policy prints in the next ≈3 weeks. If you believe the Politburo finally adds explicit RRR/rate-cut language, ASHR could break above $36.50 gamma resistance and target $37.00–$38.00 (the call wall).

Trade idea: Buy ASHR August 21, 2026 $37 calls. August OPEX implied range upper bound is $39.53, so $37 is within the one-standard-deviation cone. You're betting that a Politburo catalyst closes the 2.5% gap to the 52-week high. Premium will be modest (ASHR isn't a high-IV name — expect ≈$0.40–$0.60 for the $37 call).

Honest risk: This is a short-dated directional bet on a binary macro event. If Q2 GDP is too hot (delays easing) and Politburo again disappoints, ASHR could dip to $35.00 gamma support and these calls expire worthless. Never size this more than 1–2% of a portfolio. The institutional block cross on the put side suggests someone is hedging against exactly this scenario.

📈 Swing Trader — Trade the Gamma Map

The setup: The gamma structure gives you a clean framework — $36.00 is the Very Strong support floor (1.1% below) and $38.00 is the Dominant Call Wall (4.4% above). The monthly implied range ($34.37–$38.41) nearly matches this level-to-level.

Trade idea: Buy ASHR shares near $36.00 gamma support (or at current levels if you're comfortable with the July catalyst risk), with a mental stop on a close below $35.00 (the next floor). Initial target: $37.00 on a Politburo catalyst; extended target: $38.00 call wall on a sustained rally. If you want to replicate — at retail scale — what this institution just did, buy shares AND purchase the January 2027 $33 put for ≈$1.75 as tail insurance. That's a married-put structure: you participate in the upside but you're protected if ASHR falls below $33 by January 2027.

Position management: Below $35.00 with volume = macro thesis challenged. Either reduce the position or let the put insurance do its job.

🛡️ Premium Collector — Sell the Tight Range

The setup: ASHR is pinned between $36.00 support and $36.50 resistance (a 50-cent range!) right now. The monthly implied move of ±$2.02 implies a range of $34.37–$38.41 through July 17 OPEX. If you believe ASHR stays contained while the macro digests the PMI data and waits for the GDP print, there's a defined-premium opportunity.

Trade idea: Sell an iron condor expiring July 17, 2026 — sell the $35 put / buy the $33 put (downside wing), and sell the $38 call / buy the $39 call (upside wing). You collect premium if ASHR stays between $35 and $38 over the next 16 days.

Critical caveat: Q2 GDP drops ≈July 15 — just 2 days before this expiry. That makes this an earnings-style binary structure, not a calm theta decay trade. The GDP print could gap ASHR outside your condor wings. Size very conservatively (well under 1% of portfolio) and be ready to close early if ASHR breaks the $36.00–$36.50 gamma range before July 15. This is not a passive collect-and-forget trade.

🌱 Beginner / Entry Level — Start Simple

Real talk: The trade we're analyzing today is complex institutional infrastructure — a $16.5M combined package (puts + stock) crossed off-market between two professional counterparties. There is no straightforward retail way to replicate it, and you probably shouldn't try.

What you can do if you're bullish on China macro: Buy ASHR shares. At ≈17x P/E, the CSI 300 isn't expensive compared to U.S. large-cap. You get clean exposure to the yuan appreciation story, PBOC easing runway, and A-share momentum without option complexity. If you want to add protection the simple way, you can buy a single ASHR January 2027 $33 put for ≈$1.75 per 100 shares of ASHR you own — that's the retail version of what the institution just did.

The single most important lesson from this trade: A "$2.3M put buy" headline isn't always what it seems. Reading the full tape — seeing the paired 399,000-share block, computing the delta — completely changes the interpretation. Context beats headlines every time. That's the key skill to build as an options flow reader.


⚠️ Risks and Honest Limits

What the tape cannot confirm:

  • 🔒 Sign of the stock leg: We know a 399,000-share ASHR block crossed at the same instant, and the 90.5% delta match is strong circumstantial evidence of a delta-hedged package. But public OPRA data does not confirm whether the stock leg is a new purchase (buying into a long position) or a roll/transfer. If the stock leg is actually a sale — creating a synthetic short (long put + short stock) — the interpretation inverts completely from protective-hedge to directional-short. The prompt's verified forensic analysis indicates the long-stock interpretation is most consistent with the observed delta math, but be aware this remains inferred, not proven from public data alone.
  • 🔒 Identity and intent: We cannot know the desk, the fund, or whether the two legs belong to the same account.
  • Open vs. close — now RESOLVED (OPEN confirmed): The next-day OPRA OI snapshot is in and open interest at the $33 put rose ≈12,846 (1,221 → 14,067), closely matching the 13,000-contract size. This confirms a genuine new opening long-put position (BTO), not a BTC close of a prior short put.

China macro risks:

  • 📉 "Good-news-is-bad-news" policy trap: A strong Q2 GDP or hawkish-leaning Politburo reduces PBOC easing urgency, potentially frustrating the easing-priced market. Resilient Q1 at 5.0% already pushed rate-cut timing back; a repeat in Q2 could do the same.
  • 🏠 Property still falling: China resale home prices fell 0.42% MoM in June 2026 — accelerating from May's 0.32%. Morningstar sees 1-2 more years to clear excess supply. This structural drag on household wealth and domestic demand is real and ongoing.
  • 📊 Narrow recovery base: The June NBS PMI shows employment still contractionary at 48.4 — the recovery is export/AI-led while domestic demand stays subdued. A global tech slowdown or export deceleration could undercut the growth floor.
  • 🏷️ Tariff truce hard deadline — November 10, 2026: The pause is not permanent. Any breakdown around the November renewal — new tech/export controls, a diplomatic rupture — would reprice ASHR meaningfully lower. The $33 put provides tail protection in precisely this scenario.
  • 💱 RMB reversal risk: The entire structural bull thesis for ASHR rests on continued yuan appreciation. A renewed dollar surge or capital-outflow episode would break the "confidence loop" and compress ASHR's USD NAV directly.
  • ⚠️ Structure-over-stimulus: Beijing has consistently preferred targeted/structural measures over large demand-side packages. Investors pricing in a big PBOC/fiscal bazooka may be repeatedly disappointed.

🎯 The Bottom Line

Here's the deal: The $2.3M headline on this ASHR put cross is real money — but it is almost certainly downside insurance on a long China A-shares position, not a standalone bearish bet. The OPRA tape tells us two things happened simultaneously: a large put block was crossed AND 399,000 shares of ASHR stock were crossed at the same instant, with a 90.5% delta match between the two. That's not a coincidence — that's a married-put package.

What this trade actually signals about China:

  • ✅ A large institution has a meaningful long commitment to China A-shares — you don't pay for $14.5M of ASHR stock and $2.3M of protective puts simultaneously unless you're genuinely long-term bullish on the thesis
  • ✅ They're paying ≈4.8% of spot for 6.5-month tail coverage — the $33 put is insurance against specific scenarios: tariff truce collapse, RMB reversal, or a major China policy disappointment
  • 📊 The macro calendar is dense with binary events: Q2 GDP ≈July 15, Politburo late July, monthly LPR fixings, November 10 tariff truce renewal, December CEWC — this is a well-hedged position entering a risk-heavy period

Mark your calendar — Key dates:

  • 📅 ≈July 15, 2026 — Q2 GDP release (binary event; most important near-term catalyst)
  • 📅 July 17, 2026 — Monthly OPEX (±$2.02 / ±5.54% implied range)
  • 📅 Late July 2026 — Politburo economic meeting (H2 policy tone — the key macro signal)
  • 📅 Monthly, 20th of each month — LPR fixing (potential PBOC easing surprise)
  • 📅 November 10, 2026 — Tariff truce renewal deadline (hard catalyst in this put's window)
  • 📅 December 2026 — CEWC (2027 policy framing)
  • 📅 January 15, 2027 — Expiration of this $2.3M put position

Final verdict: ASHR sits at a genuine macro inflection point — CSI 300 at 4½-year highs, yuan below 7.00, PBOC with room to ease, and a stabilized U.S.-China trade backdrop. But "stabilized" does not mean "resolved": the Politburo's reluctance to add explicit easing language, a still-falling property market, and a tariff truce with a hard expiry date are real uncertainties. The institution that crossed $2.3M in puts alongside $14.5M in stock clearly believes the upside case but wants protection for the tail. That is the rational posture for managing China exposure right now. At ≈17x P/E, the upside case is undemanding — but macro tails are real, and buying insurance before a catalyst-dense period is good portfolio hygiene.

The $36.00 gamma floor is your near-term compass. Hold above it and the upside targets are $37.00 and $38.00. Break below $35.00 with volume and the macro thesis deserves a re-evaluation.

Disclaimer: Options trading involves substantial risk of loss and may not be suitable for all investors. This analysis is for educational and informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. China ETFs carry unique risks including currency risk (RMB/USD), political and regulatory risk, limited transparency, and policy uncertainty. The institutional block cross described here involves large-scale portfolio management strategies and risk capital not appropriate for direct retail replication. The delta-hedge interpretation is inferred from simultaneous tick-matched tape evidence and independently computed Black-Scholes delta — it is not proven from public data alone. Always conduct your own research and consider consulting a licensed financial professional before making investment decisions.


About Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR): A DWS/Harvest-managed ETF tracking the CSI 300 Index of China's 300 largest onshore A-share companies. AUM ≈$1.8B. The first U.S.-listed ETF to directly hold mainland China A-shares.

Last updated: 2026-07-02 — open/close resolved via next-day OPRA OI (reflecting July 1 EOD).

The Options Desk tracks the move options price into every US earnings report the week of Sep 7, next to how much each stock has actually moved on its past prints — plus the SPY, QQQ and IWM expected ranges and the gamma walls that box them in.